NASDAQ · Drug Manufacturers - Specialty & Generic
Organogenesis Holdings Inc (ORGO)
$1.29
+0.78%
33
In band
Moving averages
SMA 200$3.02-57.28%
Company profile
Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures and markets solutions for the advanced wound care and surgical and sports medicine markets in the United States. The company is headquartered in Canton, Massachusetts.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market cap$191.73M
P/E ratioNone
EPS$-0.79
Beta1.286
Dividend yield0.00%
52-week high$7.08
52-week low$1.47
Similar stocks in Drug Manufacturers - Specialty & Generic
HIMS
Hims & Hers Health Inc - Class A
RSI 57
CGC
Canopy Growth Corporation
RSI 28
BFRI
Biofrontera Inc
RSI 36
TLRY
Tilray Brands Inc - Class 2
RSI 33
LNTH
Lantheus Holdings Inc
RSI 48
ACB
Aurora Cannabis Inc
RSI 67
BCRX
Biocryst Pharmaceuticals Inc
RSI 49
INM
InMed Pharmaceuticals Inc
RSI 50
ZTS
Zoetis Inc - Class A
RSI 57
AQST
Aquestive Therapeutics Inc
RSI 52
RSI alerts for ORGO
Get an email the moment Organogenesis Holdings Inc crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 13 September 2026 at 7:48 AM EDT